Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Nuclear Medicine Market Segmentation, By Product
7.1 Chapter Overview
7.2 Diagnostics
7.2.1 Diagnostics Market Trends Analysis (2020-2032)
7.2.2 Diagnostics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 SPECT
7.2.3.1 SPECT Market Trends Analysis (2020-2032)
7.2.3.2 SPECT Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3.3 TC-99m
7.2.3.3.1 TC-99m Market Trends Analysis (2020-2032)
7.2.3.3.2 TC-99m Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3.4 TL-201
7.2.3.4.1 TL-201 Market Trends Analysis (2020-2032)
7.2.3.4.2 TL-201 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3.5 GA-67
7.2.3.5.1 GA-67 Market Trends Analysis (2020-2032)
7.2.3.5.2 GA-67 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3.6 I-123
7.2.3.6.1 I-123 Market Trends Analysis (2020-2032)
7.2.3.6.2 I-123 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3.7 Others
7.2.3.7.1 Others Market Trends Analysis (2020-2032)
7.2.3.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 PET
7.2.4.1 PET Market Trends Analysis (2020-2032)
7.2.4.2 PET Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4.3 F-18
7.2.4.3.1 F-18 Market Trends Analysis (2020-2032)
7.2.4.3.2 F-18 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4.4 SR-82/RB-82
7.2.4.4.1 SR-82/RB-82 Market Trends Analysis (2020-2032)
7.2.4.4.2 SR-82/RB-82 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4.5 PYLARIFY (piflufolastat F 18)
7.2.4.5.1 PYLARIFY (piflufolastat F 18) Market Trends Analysis (2020-2032)
7.2.4.5.2 PYLARIFY (piflufolastat F 18) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4.6 Illuccix (gallium Ga 68 gozetotide)
7.2.4.6.1 Illuccix (gallium Ga 68 gozetotide) Market Trends Analysis (2020-2032)
7.2.4.6.2 Illuccix (gallium Ga 68 gozetotide) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4.7 Others
7.2.4.7.1 Others Market Trends Analysis (2020-2032)
7.2.4.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Therapeutics
7.3.1 Therapeutics Market Trends Analysis (2020-2032)
7.3.2 Therapeutics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Alpha Emitters
7.3.3.1 Alpha Emitters Market Trends Analysis (2020-2032)
7.3.3.2 Alpha Emitters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.3 RA-223
7.3.3.3.1 RA-223 Market Trends Analysis (2020-2032)
7.3.3.3.2 RA-223 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.4 Others
7.3.3.4.1 Others Market Trends Analysis (2020-2032)
7.3.3.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Beta Emitters
7.3.4.1 Beta Emitters Market Trends Analysis (2020-2032)
7.3.4.2 Beta Emitters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.3 I-131
7.3.4.3.1 I-131 Market Trends Analysis (2020-2032)
7.3.4.3.2 I-131 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.4 Y-90
7.3.4.4.1 Y-90 Market Trends Analysis (2020-2032)
7.3.4.4.2 Y-90 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.5 SM-153
7.3.4.5.1 SM-153 Market Trends Analysis (2020-2032)
7.3.4.5.2 SM-153 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.6 Re-186
7.3.4.6.1 Re-186 Market Trends Analysis (2020-2032)
7.3.4.6.2 Re-186 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.7 Lu-177
7.3.4.7.1 Lu-177 Market Trends Analysis (2020-2032)
7.3.4.7.2 Lu-177 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.8 Others
7.3.4.8.1 Others Market Trends Analysis (2020-2032)
7.3.4.8.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Brachytherapy
7.3.5.1 Brachytherapy Market Trends Analysis (2020-2032)
7.3.5.2 Brachytherapy Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5.3 Cesium-131
7.3.5.3.1 Cesium-131 Market Trends Analysis (2020-2032)
7.3.5.3.2 Cesium-131 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5.4 Iodine-125
7.3.5.4.1 Iodine-125 Market Trends Analysis (2020-2032)
7.3.5.4.2 Iodine-125 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5.5 Palladium-103
7.3.5.5.1 Palladium-103 Market Trends Analysis (2020-2032)
7.3.5.5.2 Palladium-103 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5.6 Iridium-192
7.3.5.6.1 Iridium-192 Market Trends Analysis (2020-2032)
7.3.5.6.2 Iridium-192 Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5.7 Others
7.3.5.7.1 Others Market Trends Analysis (2020-2032)
7.3.5.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Nuclear Medicine Market Segmentation, By Application
8.1 Chapter Overview
8.2 Cardiology
8.2.1 Cardiology Market Trends Analysis (2020-2032)
8.2.2 Cardiology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 SPECT
8.2.3.1 SPECT Market Trends Analysis (2020-2032)
8.2.3.2 SPECT Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 PET
8.2.4.1 PET Market Trends Analysis (2020-2032)
8.2.4.2 PET Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Therapeutic Applications
8.2.5.1 Therapeutic Applications Market Trends Analysis (2020-2032)
8.2.5.2 Therapeutic Applications Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Neurology
8.3.1 Neurology Market Trends Analysis (2020-2032)
8.3.2 Neurology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Oncology
8.4.1 Oncology Market Trends Analysis (2020-2032)
8.4.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Thyroid
8.5.1 Thyroid Market Trends Analysis (2020-2032)
8.5.2 Thyroid Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5.3 SPECT
8.5.3.1 SPECT Market Trends Analysis (2020-2032)
8.5.3.2 SPECT Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5.4 Therapeutic Applications
8.5.4.1 Therapeutic Applications Market Trends Analysis (2020-2032)
8.5.4.2 Therapeutic Applications Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Lymphoma
8.6.1 Lymphoma Market Trends Analysis (2020-2032)
8.6.2 Lymphoma Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Bone Metastasis
8.7.1 Bone Metastasis Market Trends Analysis (2020-2032)
8.7.2 Bone Metastasis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.8 Endocrine Tumor
8.8.1 Endocrine Tumor Market Trends Analysis (2020-2032)
8.8.2 Endocrine Tumor Market Size Estimates and Forecasts to 2032 (USD Billion)
8.9 Pulmonary Scans
8.9.1 Pulmonary Scans Market Trends Analysis (2020-2032)
8.9.2 Pulmonary Scans Market Size Estimates and Forecasts to 2032 (USD Billion)
8.10 Other
8.10.1 Other Market Trends Analysis (2020-2032)
8.10.2 Other Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Nuclear Medicine Market Segmentation, By End-use
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Diagnostic Centers
9.3.1 Diagnostic Centers Market Trends Analysis (2020-2032)
9.3.2 Diagnostic Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Others
9.4.1 Others Market Trends Analysis (2020-2032)
9.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.4 North America Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.5 North America Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.6.2 USA Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.6.3 USA Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.7.2 Canada Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.7.3 Canada Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.7.2 France Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.7.3 France Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.6.2 China Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.6.3 China Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.7.2 India Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.7.3 India Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.8.2 Japan Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.8.3 Japan Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.12.2 Australia Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.12.3 Australia Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.4 Africa Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.5 Africa Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Nuclear Medicine Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.4 Latin America Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.5 Latin America Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Nuclear Medicine Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Nuclear Medicine Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Nuclear Medicine Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
11. Company Profiles
11.1 GE HealthCare
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Siemens Healthineers
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Philips Healthcare
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Canon Medical Systems Corporation
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Lantheus Medical Imaging, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Bracco Imaging S.p.A
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Cardinal Health
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Eckert & Ziegler
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Nordion (Canada), Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 NTP Radioisotopes SOC Ltd.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
